Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy, Safety & Tolerability of Combination of Ertugliflozin and Sitagliptin in Patients With Type II Diabetes Mellitus

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05556291
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:43.016983+00:00
Published At
2025-03-20T00:00:00+00:00
Record Updated At
2025-03-20
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Efficacy", "Safety", "Tolerability"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-03-20"
protocolSection.identificationModule.nctId
"NCT05556291"
protocolSection.identificationModule.officialTitle
"Efficacy, Safety \u0026 Tolerability of Combination of Ertugliflozin and Sitagliptin in Patients With Type II Diabetes Mellitus"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Efficacy (protocolSection.conditionsModule.conditions)
  • Safety (protocolSection.conditionsModule.conditions)
  • Tolerability (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.